PEAK6 Investments’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,202
Closed -$265K 3714
2024
Q2
$265K Sell
3,202
-2,090
-39% -$184K ﹤0.01% 2620
2024
Q1
$452K Buy
+5,292
New +$415K ﹤0.01% 2516
2023
Q4
Sell
-3,289
Closed -$295K 4472
2023
Q3
$295K Buy
+3,289
New +$294K ﹤0.01% 2792
2023
Q2
Sell
-772
Closed -$63.9K 4213
2023
Q1
$63.9K Buy
+772
New +$62.5K ﹤0.01% 3681
2022
Q4
Sell
-2,818
Closed -$226K 4737
2022
Q3
$209K Buy
+2,818
New +$202K ﹤0.01% 3620
2022
Q1
Sell
-15,998
Closed -$849K 5505
2021
Q4
$849K Sell
15,998
-8,094
-34% -$493K ﹤0.01% 2705
2021
Q3
$1.7M Buy
24,092
+23,264
+2,810% +$1.47M ﹤0.01% 2124
2021
Q2
$55K Buy
+828
New +$58.6K ﹤0.01% 4576
2020
Q4
Sell
-13,157
Closed -$1.42M 4800
2020
Q3
$1.15M Sell
13,157
-4,458
-25% -$390K ﹤0.01% 2147
2020
Q2
$1.58M Buy
17,615
+15,804
+873% +$1.6M 0.01% 1689
2020
Q1
$180K Buy
+1,811
New +$196K ﹤0.01% 2938
2019
Q4
Sell
-2,319
Closed -$293K 3644
2019
Q3
$293K Buy
2,319
+63
+3% +$8K ﹤0.01% 2657
2019
Q2
$271K Sell
2,256
-776
-26% -$76.3K ﹤0.01% 2671
2019
Q1
$265K Sell
3,032
-2,273
-43% -$207K ﹤0.01% 2788
2018
Q4
$531K Buy
5,305
+2,303
+77% +$242K ﹤0.01% 2288
2018
Q3
$344K Buy
+3,002
New +$311K ﹤0.01% 2852

Other funds holding HAE

PEAK6 Investments's HAE Position: Q3 2024 in Review

PEAK6 Investments sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 3,202 shares — an estimated $265K sold.

PEAK6 Investments first reported a position in HAE in Q3 2018 and held it in 16 quarters. The position peaked at $1.7M in Q3 2021. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • PEAK6 Investments reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 3,202 Haemonetics shares in Q3 2024, an estimated $265K.
  • PEAK6 Investments first reported a position in Haemonetics in Q3 2018 and held it in 16 quarters.
  • PEAK6 Investments's Haemonetics position peaked at $1.7M in Q3 2021.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.